We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The review will examine the harm that drugs cause and look at prevention, treatment and recovery.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
The review of the safety of isotretinoin has concluded.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
How to use feedback from marketplace reviews to evaluate your digital health product.
How to show the MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).